JITSUBO
Yokohama
About JITSUBO
JITSUBO aims to be a Peptide Lowest Cost Producer by continuously improving core technologies by incorporating all the latest technologies. JITSUBO company name is derived from "Chiba Jitsubo-san", a family business of Kazuhiro Chiba, a science and technology adviser and co-founder. Chiba Minorusan is a rare medicine that has been contributing to the health of people for over 500 years as a herbal medicine for women. The company named 'JITSUBO' from the desire to provide products that are useful for people's health through peptide drugs for a long time. We aim to be such a great mother-like company that continues to bring the results of technological innovation to the value of superior peptide drugs and continue to produce them in society.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $23.5M
- Funding stage: M&A
- Last round: Series Unknown (Nov 2016)
- Website: jitsubo.com
- Phone: +81 045-633-4327
Industries & Categories
Chemical, Embedded Systems, Medical, Nursing and Residential Care
Canonical: https://fsome.com/organization/jitsubo-196413 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.